Lina Posada Calderon, MD, discusses the background and key takeaways from her team’s study examining germline BAP1-associated renal cell carcinoma.
Lina Posada Calderon, MD
Advertisement
Articles by Lina Posada Calderon, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants 510(k) clearance to Break Wave lithotripsy device for kidney stones
2
CaverSTIM device shows initial promise for post-prostatectomy erectile dysfunction
3
Initial ARID results published in World Journal of Urology as pivotal trial progresses
4
ProFam-Risk registry aims to establish model for personalized prostate cancer prevention
5